BioMark Closes Second Tranche of Private Placement Offering
June 24, 2016 08:00 ET
|
BioMark Diagnostics Inc.
VANCOUVER, British Columbia, June 24, 2016 (GLOBE NEWSWIRE) -- BioMark Diagnostics Inc. (“BioMark” or the “Company”) (CSE:BUX) (FSE:20B) (OTCQB:BMKDF) is pleased to announce that further to its...
BioMark Engages Stockhouse.com Deal Room with Private Placement
June 20, 2016 08:00 ET
|
BioMark Diagnostics Inc.
VANCOUVER, British Columbia, June 20, 2016 (GLOBE NEWSWIRE) -- BioMark Diagnostics Inc. (“BioMark” or the “Company”) (CSE:BUX) (FSE:20B) (OTCQB:BMKDF) is pleased to announce it has engaged...
BioMark Receives Approval for Its Lung Cancer Treatment Protocol
March 29, 2016 08:00 ET
|
BioMark Diagnostics Inc.
VANCOUVER, British Columbia, March 29, 2016 (GLOBE NEWSWIRE) -- BioMark Diagnostics Inc. (“BioMark” or the “Company”) (CSE:BUX) (FSE:20B) (OTCQB:BMKDF) is pleased to announce that it has now...
BioMark Closes First Tranche of Private Placement Offering
March 15, 2016 08:00 ET
|
BioMark Diagnostics Inc.
VANCOUVER, British Columbia, March 15, 2016 (GLOBE NEWSWIRE) -- BioMark Diagnostics Inc. (“BioMark” or the “Company”) (CSE:BUX) (FSE:20B) (OTCQB:BMKDF) is pleased to announce that further to its...
BioMark Announces Private Placement Offering
March 09, 2016 16:45 ET
|
BioMark Diagnostics Inc.
VANCOUVER, British Columbia, March 09, 2016 (GLOBE NEWSWIRE) -- BioMark Diagnostics Inc. (“BioMark” or the “Company”) (CSE:BUX) (FSE:20B) (OTCQB:BMKDF) is pleased to announce a non-brokered Private...
BioMark Announces Progress Towards Data Analysis
February 16, 2016 08:00 ET
|
BioMark Diagnostics Inc.
VANCOUVER, British Columbia, Feb. 16, 2016 (GLOBE NEWSWIRE) -- BioMark Diagnostics Inc. (“BioMark”) (CSE:BUX) (FSE:20B) (OTCQB:BMKDF) announces that BioMark has completed the internal standards for...
BioMark Diagnostics to Conduct Validation Studies for Its Patented Assays in Patients With Lung Cancer
September 10, 2015 08:00 ET
|
BioMark Diagnostics Inc.
VANCOUVER, British Columbia, Sept. 10, 2015 (GLOBE NEWSWIRE) -- BioMark Diagnostics Inc. ("BioMark") (CSE:BUX) (FSE:20B) (OTCQB:BMKDF) announces that it expects to begin conducting studies in the...
BioMark Diagnostics Receives Clearance From Health Canada to Commence Clinical Trial With Patented Non-Invasive, Urine-Based Assay to Measure Response to Treatment for Lung Cancer
September 09, 2015 08:00 ET
|
BioMark Diagnostics Inc.
VANCOUVER, British Columbia, Sept. 9, 2015 (GLOBE NEWSWIRE) -- BioMark Diagnostics Inc. ("BioMark") (CSE:BUX) (FSE:20B) (OTCQB:BMKDF) announces receipt of a No Objection Letter from Health Canada,...
BioMark Diagnostics to Present at Rodman & Renshaw Global Investment Conference
September 03, 2015 08:00 ET
|
BioMark Diagnostics Inc.
VANCOUVER, British Columbia, Sept. 3, 2015 (GLOBE NEWSWIRE) -- BioMark Diagnostics Inc. ("BioMark") (CSE:BUX) (FSE:20B) (OTCQB:BMKDF) announces that President and CEO Rashid Ahmed will present a...
BioMark Diagnostics to Present at Rodman & Renshaw Global Investment Conference
September 03, 2015 08:00 ET
|
BioMark Diagnostics Inc.
VANCOUVER, British Columbia, Sept. 3, 2015 (GLOBE NEWSWIRE) -- BioMark Diagnostics Inc. ("BioMark") (CSE:BUX) (FSE:20B) (OTCQB:BMKDF) announces that President and CEO Rashid Ahmed will present a...